Micro-organisms are important for both human health and to industry so the fed-batch cultivation of microbial strains, often over expressing recombinant or natural proteins, to high cell density has become an increasingly important technique throughout the field of biotechnology, from basic research programmes to large-scale pharmaceutical production processes (Hewitt et al., 1999). The scale-up of such a process is usually the final step in any research and development programme leading to the large-scale industrial manufacture of such products by fermentation (Einsele, 1978). It is important to understand that the process of scaling-up a fermentation system is frequently governed by a number of important engineering considerations and not...
A fundamental discrepancy in process performance (yields) exists between laboratory and industrial s...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
Successful bioprocess scale up requires an understanding of the microenvironment influenced by biore...
Scaled‐down models are small‐scale bioreactors, used to mimic the chemical (pH, nutrient and dissolv...
BACKGROUND: The loss of efficiency and performance of bioprocesses on scale-up is well known, but no...
Since the inception of biopharmaceutical industry, scale up issues hampered the success of process t...
For commercialization, strain and bioprocess developments need to be successfully transferred from t...
Bioreactor or fermenter is the heart of a process. Scaling up a bioreactor and maintaining the same ...
Microbial fermentations are used to produce pharmaceuticals, chemicals, and fuels. Side product form...
BACKGROUNDThe loss of efficiency and performance of bioprocesses on scale‐up is well known, but not ...
The bio-economy is in transit from innovation to commercialization. The bioprocess industry is expec...
Systems biology and synthetic biology are increasingly used to examine and modulate complex biologic...
A fundamental discrepancy in process performance (yields) exists between laboratory and industrial s...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
Successful bioprocess scale up requires an understanding of the microenvironment influenced by biore...
Scaled‐down models are small‐scale bioreactors, used to mimic the chemical (pH, nutrient and dissolv...
BACKGROUND: The loss of efficiency and performance of bioprocesses on scale-up is well known, but no...
Since the inception of biopharmaceutical industry, scale up issues hampered the success of process t...
For commercialization, strain and bioprocess developments need to be successfully transferred from t...
Bioreactor or fermenter is the heart of a process. Scaling up a bioreactor and maintaining the same ...
Microbial fermentations are used to produce pharmaceuticals, chemicals, and fuels. Side product form...
BACKGROUNDThe loss of efficiency and performance of bioprocesses on scale‐up is well known, but not ...
The bio-economy is in transit from innovation to commercialization. The bioprocess industry is expec...
Systems biology and synthetic biology are increasingly used to examine and modulate complex biologic...
A fundamental discrepancy in process performance (yields) exists between laboratory and industrial s...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
Successful bioprocess scale up requires an understanding of the microenvironment influenced by biore...